σ 1 -Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl)-Piperidine Affords Neuroprotection From Focal Ischemia With Prolonged Reperfusion
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (4) , 976-982
- https://doi.org/10.1161/01.str.31.4.976
Abstract
Background and Purpose —We previously showed that the intravenous administration of the potent ς 1 -receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine (PPBP) provides neuroprotection against transient focal cerebral ischemia and that the protection depends on treatment duration. We tested the hypothesis that PPBP would provide neuroprotection in a model of transient focal ischemia and 7 days of reperfusion in the rat as assessed with neurobehavioral outcome and infarction volume. Methods —Under the controlled conditions of normoxia, normocarbia, and normothermia, halothane-anesthetized male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAO) with the intraluminal suture occlusion technique. We used laser Doppler flowmetry to assess MCAO. At 60 minutes after the onset of ischemia, rats were randomly assigned to 1 of 4 treatment groups in a blinded fashion and received a continuous intravenous infusion of control saline or 0.1, 1, or 10 μmol · kg −1 · h −1 PPBP for 24 hours. Neurobehavioral evaluation was performed at baseline (3 to 4 days before MCAO) and at 3 and 7 days of reperfusion. Infarction volume was assessed with triphenyltetrazolium chloride staining on day 7 of reperfusion in all rats. Results —Triphenyltetrazolium chloride–determined infarction volume of ipsilateral cortex was smaller in rats treated with 10 μmol · kg −1 · h −1 PPBP (n=15, 68±12 mm 3 , 18±3% of contralateral structure, P 3 , 31±3% of contralateral structure). PPBP did not provide significant neuroprotection in the caudoputamen complex. Although MCAO was associated with several alterations in behavior, the treatment with PPBP had no effect on behavioral outcomes. Conclusions —The data demonstrate that the potent ς 1 -receptor ligand PPBP decreases cortical infarction volume without altering neurobehavior after transient focal ischemia and prolonged reperfusion in the rat.Keywords
This publication has 23 references indexed in Scilit:
- Neuroprotection from Focal Ischemia by 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Dependent on Treatment Duration in RatsAnesthesia & Analgesia, 1998
- Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brainEuropean Neuropsychopharmacology, 1996
- Environment, Social Interaction, and Physical Activity as Determinants of Functional Outcome after Cerebral Infarction in the RatExperimental Neurology, 1996
- Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell cultureSynapse, 1995
- In vivo labeling of sigma receptors in mouse brain with [3H]4‐phenyl‐1‐(4‐phenylbutyl)piperidineSynapse, 1995
- The Significance of Brain Temperature in Focal Cerebral Ischemia: Histopathological Consequences of Middle Cerebral Artery Occlusion in the RatJournal of Cerebral Blood Flow & Metabolism, 1992
- THE INCIDENCE OF THE GRASP REFLEX FOLLOWING HEMISPHERIC LESION AND ITS RELATION TO FRONTAL DAMAGEBrain, 1992
- CGS‐19755, A competitive NMDA receptor antagonist, reduces calcium‐calmodulin binding and improves outcome after global cerebral ischemiaAnnals of Neurology, 1990
- Small Differences in Intraischemic Brain Temperature Critically Determine the Extent of Ischemic Neuronal InjuryJournal of Cerebral Blood Flow & Metabolism, 1987
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984